FDA 483 - Imran S. Khawaja, M.D. - May 06, 2025

Imran S. Khawaja, M.D., a clinical investigator in Fort Worth, TX, was cited for failing to conduct an investigation in accordance with the investigational plan. The inspection revealed multiple instances where subjects were enrolled in studies without meeting eligibility criteria, including missing required laboratory tests and being on exclusionary medications. This indicates significant deviations from study protocols.